Fasting plasma peptide-YY concentrations are elevated but do not rise postprandially in type 2 diabetes [4]

Diabetologia

Volumn 49, Issue 9, 2006, Pages 2219-2221

  English, P J ^a   Ashcroft, A ^b   Patterson, M ^c   Dovey, T M ^b   Halford, J C G ^b   Harrison, J ^a   Eccleston, D ^a   Bloom, S R ^c   Ghatei, M A ^c   Wilding, J P H ^a  

^a UNIVERSITY HOSPITAL AINTREE   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; AUTOANTIBODY; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; GHRELIN; INSULIN; PEPTIDE YY; SULFONYLUREA;

ADULT; ANTHROPOMETRY; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; ENERGY EXPENDITURE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LETTER; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POSTPRANDIAL STATE; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

ADULT; DIABETES MELLITUS, TYPE 2; FASTING; GHRELIN; HUMANS; MIDDLE AGED; PEPTIDE HORMONES; PEPTIDE YY; POSTPRANDIAL PERIOD;

EID: 33746706959     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-006-0344-y     Document Type: Letter

References (12)

1. Wing RR, Marcus MD, Epstein LH, Salata R (1987) Type II diabetic subjects lose less weight than their overweight nondiabetic spouses. Diabetes Care 10:563-566
2. Adrian TE, Ferri GL, Bacarese-Hamilton AJ, Fuessl HS, Polak JM, Bloom SR (1985) Human distribution and release of a putative new gut hormone, peptide YY. Gastroenterology 89:1070-1077
3. Batterham RL, Cohen MA, Ellis SM et al (2003) Inhibition of food intake in obese subjects by peptide YY3-36. N Engl J Med 349:941-948
4. Batterham RL, Cowley MA, Small CJ et al (2002) Gut hormone PYY (3-36) physiologically inhibits food intake. Nature 418:650-654
5. Wren AM, Small CJ, Abbott CR et al (2001) Ghrelin causes hyperphagia and obesity in rats. Diabetes 50:2540-2547
6. Wren AM, Seal LJ, Cohen MA et al (2001) Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab 86:5992
7. Tschop M, Smiley DL, Heiman ML (2000) Ghrelin induces adiposity in rodents. Nature 407:908-913
8. English PJ, Ghatei MA, Malik IA, Bloom SR, Wilding JP (2002) Food fails to suppress ghrelin levels in obese humans. J Clin Endocrinol Metab 87:2984-2987
9. Toft-Nielsen MB, Damholt MB, Madsbad S et al (2001) Determinants of the impaired secretion of glucagon-like peptide-1 in type 2 diabetic patients. J Clin Endocrinol Metab 86:3717-3723
10. Vilsboll T, Agerso H, Krarup T, Holst JJ (2003) Similar elimination rates of glucagon-like peptide-1 in obese type 2 diabetic patients and healthy subjects. J Clin Endocrinol Metab 88:220-224
11. Meneilly GS, Demuth HU, McIntosh CH, Pederson RA (2000) Effect of ageing and diabetes on glucose-dependent insulinotropic polypeptide and dipeptidyl peptidase IV responses to oral glucose. Diabet Med 17:346-350
12. Mannucci E, Pala L, Ciani S et al (2005) Hyperglycaemia increases dipeptidyl peptidase IV activity in diabetes mellitus. Diabetologia 48:1168-1172